Journal of the Korean Ophthalmological Society 2003;44(1):81-85.
Published online January 1, 2003.
The Changes in Intraocular Pressure Following the Combined Treatment of Systemic Acetazolamide and Topical Dorzolamide.
Tae Kyung Park, Jung Il Moon, Chan Kee Park
1Department of Ophthalmology, St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. jimoon@catholic.ac.kr
2Department of Ophthalmology, Kang-Nam St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
개방각녹내장 환자에서 탄산탈수효소 억제제 전신 복용제와 국소 점안제 복합 사용에 따른 안압의 변화
박태경 ( Tae Kyung Park ) , 문정일 ( Jung Il Moon ) , 박찬기 ( Chan Kee Park )
Abstract
PURPOSE
This study is to determine whether topical dorzolamide and systemic acetazolamide have an additive effect on the changes in intraocular pressure (IOP) in patients with open angle glaucoma. METHODS: Twenty eyes of 10 patients being treated with only acetazolamide (Group 1) and 20 eyes of 10 patients being treated with only dorzolamide (Group 2) were included in this study. Dorzolamide was additionally applied three times a day to Group 1 and acetazolamide 250 mg three times a day was additionally given to Group 2. Changes in intraocular pressure and complications due to overdose of carbonic anhydrase inhibitors (CAIs) were checked 1, 2, and 4 weeks after the additional treatment. RESULTS: The IOP was reduced 1.0+/-2.9% (N=20) (p>0.05) from the baseline pressure checked before the additional treatment in Group 1 and 13.2+/-3.6% (N=16) (p<0.01) in Group 2. No significant complication due to CAI usage was observed. CONCLUSIONS: In patients with open angle glaucoma, combination therapy of systemic and topical CAIs was effective only when additional systemic CAI was given to the cases using topical agents.
Key Words: Acetazolamide;Dorzolamide;Open angle glaucoma


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next